Large and toxic doses of
phenytoin have been observed to cause hyperglycaemia, but normal therapeutic doses do not usually affect the
control of
diabetes. Two isolated cases of
phenytoin toxicity have been attributed to the use of
tolazamide or
tolbutamide.
No interaction of
clinical importance normally occurs and so no special precautions would seem to be necessary.